SCHEMBL12196153

SCHEMBL12196153

CCCC[C@@H](C)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8194495 1.00
SCHEMBL276837 1.00
Hydrochloric Acid SCHEMBL7409622 0.98 CA2 (0.56)
SCHEMBL1827755 0.93 CA1 (0.61)
SCHEMBL1827758 0.93 CA1 (0.61)
SCHEMBL122044 0.93 CA1 (0.61)
Formic Acid SCHEMBL29184482 0.91 CA1 (0.50)
SCHEMBL18229264 0.91 CA1 (0.50)
SCHEMBL23857835 0.91 CA1 (0.59)
SCHEMBL10866301 0.91 CA1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030888-B2 Himastatin derivatives, and processes of preparation thereof, and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2024-07-09 US disclosed
US-20220289750-A1 HIMASTATIN DERIVATIVES, AND PROCESSES OF PREPARATION THEREOF, AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2022-09-15 US disclosed
EP-2371366-A1 Heterocyclo inhibitors of potassium channel function Bristol-Myers Squibb Company (US) 2011-10-05 EP disclosed
WO-2008106225-A1 MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2008-09-04 WO disclosed